Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

70
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
70
Depression: Overview01:18

Depression: Overview

228
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
228
Long-term Depression01:05

Long-term Depression

30.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.7K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

389
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
389
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Stress Prevention and Stress Management Techniques III01:25

Stress Prevention and Stress Management Techniques III

55
Regular exercise and meditation serve as essential tools in managing stress and promoting physical and mental well-being.
The Role of Exercise in Stress Management
Regular physical activity is essential for reducing stress and promoting cardiovascular health. Exercise strengthens the heart, enhances blood flow, keeps blood vessels flexible, and helps lower blood pressure, all of which reduce the body's stress response. Research shows that adults who exercise regularly have nearly half the...
55

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decomposing neuroanatomical heterogeneity in depression: insights from an ENIGMA major depressive disorder working group study in 5146 individuals.

Translational psychiatry·2026
Same author

The relocation of a psychiatric crisis intervention unit from a somatic to a psychiatric hospital: a multi-method observational study.

Scientific reports·2026
Same author

The long-term psychological and sleep-related consequences of the Halabja chemical attack: A cross-sectional and cross-generational study over three generations.

Journal of affective disorders·2026
Same author

Heart rate variability across recording conditions: Associations with depression and burnout in inpatients with stress-related disorders.

Journal of psychosomatic research·2026
Same author

[Recognising and treating depression - a practical overview of current treatment algorithms and evidence-based recommendations].

Therapeutische Umschau. Revue therapeutique·2026
Same author

NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmacies.

Molecular neurobiology·2026

Related Experiment Video

Updated: Jun 14, 2025

Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement
12:22

Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement

Published on: July 1, 2015

23.5K

Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study.

Jan Sarlon1, Else Schneider2, Annette B Brühl2

  • 1University of Basel, University Psychiatric Clinics (UPK), Basel, Switzerland. jan.sarlon@upk.ch.

European Archives of Psychiatry and Clinical Neuroscience
|September 4, 2024
PubMed
Summary

Mindfulness-based interventions (MBI) via mobile apps can effectively supplement standard care for Major Depressive Disorder (MDD). This study found adjunctive MBI significantly reduced depression severity and systolic blood pressure in MDD patients.

Keywords:
DepressionMindfulnessMobile applicationStress level

More Related Videos

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K
An Application for Pairing with Wearable Devices to Monitor Personal Health Status
06:58

An Application for Pairing with Wearable Devices to Monitor Personal Health Status

Published on: February 3, 2022

2.7K

Related Experiment Videos

Last Updated: Jun 14, 2025

Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement
12:22

Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement

Published on: July 1, 2015

23.5K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K
An Application for Pairing with Wearable Devices to Monitor Personal Health Status
06:58

An Application for Pairing with Wearable Devices to Monitor Personal Health Status

Published on: February 3, 2022

2.7K

Area of Science:

  • Mental Health
  • Clinical Psychology
  • Digital Health

Background:

  • Mindfulness-based interventions (MBI) are effective for Major Depressive Disorder (MDD) relapse prevention.
  • Internet-based interventions show efficacy in treating MDD.
  • Mobile app delivery of MBI offers a promising supplementary approach for MDD management in ambulatory care.

Purpose of the Study:

  • To evaluate the efficacy of adjunctive MBI via a mobile app in reducing symptom severity and stress in MDD patients.
  • To compare mobile app MBI plus standard treatment against standard treatment alone in an ambulatory setting.
  • To assess secondary outcomes including blood pressure and heart rate.

Main Methods:

  • Randomized controlled trial with 83 MDD patients allocated to MBI (daily app use for 30 days) or treatment as usual (TAU).
  • Symptom severity assessed using Beck Depression Inventory (BDI-II) and Hamilton Depression Rating Scale (HDRS-17).
  • Secondary outcomes included blood pressure and resting heart rate.

Main Results:

  • Both groups showed decreased depression scores after 30 days.
  • The MBI group demonstrated a significantly greater decrease in HDRS-17 scores compared to the TAU group.
  • Systolic blood pressure was lower in the MBI intervention group.

Conclusions:

  • Short-term (30-day) mindfulness intervention via mobile app can be a beneficial adjunctive therapy for MDD patients.
  • Mobile MBI shows potential for augmenting mental health services in ambulatory care settings.
  • Adjunctive mobile MBI may improve depression severity and cardiovascular markers in MDD.